Literature DB >> 15502885

[Main determinants of liver microcirculation during systemic inflammation].

C Wunder1, N Roewer, O Eichelbrönner.   

Abstract

More than 50% of all patients on intensive care units acquire a systemic inflammation such as systemic inflammatory response syndrome (SIRS) or sepsis. The development of hepatic microcirculatory failure with consecutive organ damage might occur during the course of the systemic inflammation. The liver microcirculation is regulated by a complex network of cellular components and specific mediators. The perfusion in liver sinusoids is regulated by the tonus of the contractile Ito cells. Nitric oxide (NO) and carbon monoxide (CO) influence each other and cause the Ito cells to dilate while endothelin results in a contraction of the Ito cells. On-going studies are investigating the role of angiotensin II, catecholamines and prostaglandins for the regulation of the hepatic microcirculatory system during systemic inflammation. Some investigations aim to determine the impact of sedatives and analgesics on the hepatic microcirculation in sepsis and SIRS. Therefore, a decisive recommendation about the choice and dosage of sedatives and analgesics for these patients is not possible. Nevertheless, ketamine, midazolam and fentanyl with their potential anti-inflammatory properties seem to be suitable for patients with systemic inflammation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15502885     DOI: 10.1007/s00101-004-0770-5

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  68 in total

Review 1.  Mechanisms of neutrophil-induced parenchymal cell injury.

Authors:  H Jaeschke; C W Smith
Journal:  J Leukoc Biol       Date:  1997-06       Impact factor: 4.962

2.  Neutrophil margination and extravasation in sinusoids and venules of liver during endotoxin-induced injury.

Authors:  J G Chosay; N A Essani; C J Dunn; H Jaeschke
Journal:  Am J Physiol       Date:  1997-05

3.  Effects of desflurane and isoflurane on splanchnic microcirculation during major surgery.

Authors:  J O'Riordan; H A O'Beirne; Y Young; M C Bellamy
Journal:  Br J Anaesth       Date:  1997-01       Impact factor: 9.166

Review 4.  The hepatic microvascular responses to sepsis.

Authors:  A Ring; W Stremmel
Journal:  Semin Thromb Hemost       Date:  2000       Impact factor: 4.180

5.  Carbon monoxide: an endogenous modulator of sinusoidal tone in the perfused rat liver.

Authors:  M Suematsu; N Goda; T Sano; S Kashiwagi; T Egawa; Y Shinoda; Y Ishimura
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

6.  Prolonged infusion of angiotensin II into normal rats induces stellate cell activation and proinflammatory events in liver.

Authors:  Ramón Bataller; Erwin Gäbele; Robert Schoonhoven; Terry Morris; Mark Lehnert; Liu Yang; David A Brenner; Richard A Rippe
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2003-05-28       Impact factor: 4.052

7.  Endothelin receptor antagonist bosentan improves microcirculatory blood flow in splanchnic organs in septic shock.

Authors:  Vladimir Krejci; Luzius B Hiltebrand; Dominique Erni; Gisli H Sigurdsson
Journal:  Crit Care Med       Date:  2003-01       Impact factor: 7.598

8.  Systemic and regional hemodynamics of isoflurane and sevoflurane in rats.

Authors:  P F Conzen; B Vollmar; H Habazettl; E J Frink; K Peter; K Messmer
Journal:  Anesth Analg       Date:  1992-01       Impact factor: 5.108

9.  Hepatic dysfunction increases length of stay and risk of death after injury.

Authors:  Brian G Harbrecht; Mazen S Zenati; Howard R Doyle; John McMichael; Ricard N Townsend; Keith D Clancy; Andrew B Peitzman
Journal:  J Trauma       Date:  2002-09

10.  Goal-directed therapy with dopexamine, dobutamine, and volume expansion: effects of systemic oxygen transport on hepatic ultrastructure in porcine sepsis.

Authors:  D Tighe; R Moss; G Heywood; N al-Saady; A Webb; D Bennett
Journal:  Crit Care Med       Date:  1995-12       Impact factor: 7.598

View more
  1 in total

1.  Phosphodiesterase-4 inhibition with rolipram attenuates hepatocellular injury in hyperinflammation in vivo and in vitro without influencing inflammation and HO-1 expression.

Authors:  Jakob Wollborn; Christian Wunder; Jana Stix; Winfried Neuhaus; Rapahel R Bruno; Wolfgang Baar; Sven Flemming; Norbert Roewer; Nicolas Schlegel; Martin A Schick
Journal:  J Pharmacol Pharmacother       Date:  2015 Jan-Mar
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.